Platinum compounds: a hope for future cancer chemotherapy.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Anti-Cancer Agents in Medicinal Chemistry

• Publication date

  2013-01-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/1871520611313020016PMID 22583420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA compaction by mononuclear platinum cancer drug cisplatin and the trisplatinum anticancer agent BBR3464: Differences and similarities.

  2012cited by this paper
• Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues.

  2012cited by this paper
• Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin

  2011cited by this paper
• Cancer Scenario in India with Future Perspectives

  2011cited by this paper
• Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects

  2011cited by this paper
• Nano anti-cancer drugs: pros and cons and future perspectives.

  2011cited by this paper
• Drug transporters of platinum-based anticancer agents and their clinical significance.

  2011cited by this paper
• Advances in nano drugs for cancer chemotherapy.

  2011cited by this paper
• Synthesis, characterization and biological activity of trans-platinum(II) complexes with chloroquine.

  2011cited by this paper
• The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin

  2010cited by this paper
• Induction chemotherapy with nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal carcinoma.

  2010cited by this paper
• Multicenter phase 2 study of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma

  2010cited by this paper
• The status of platinum anticancer drugs in the clinic and in clinical trials.

  2010cited by this paper
• Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis

  2010cited by this paper
• Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.

  2010cited by this paper
• Randomized, multicenter, phase III trial of heptaplatin 1-hour infusion and 5-fluorouracil combination chemotherapy comparing with cisplatin and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer.

  2009cited by this paper
• Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin

  2009cited by this paper
• The second-generation anticancer drug Nedaplatin: a theoretical investigation on the hydrolysis mechanism.

  2009cited by this paper
• Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethy1)-2-isopropyl-1,3-dioxolanelplatinum(II), a new platinum analogue, as an anticancer agent

  2009cited by this paper
• Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma

  2009cited by this paper
• Cytotoxic activities, cellular uptake, gene regulation, and optical imaging of novel platinum(II) complexes.

  2009cited by this paper
• Proteomic Approaches in Understanding Action Mechanisms of Metal-Based Anticancer Drugs

  2008cited by this paper
• How do real tumors become resistant to cisplatin?

  2008cited by this paper
• New trends for metal complexes with anticancer activity.

  2008cited by this paper
• Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.

  2008cited by this paper
• Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.

  2007cited by this paper
• Searching for the magic bullet: anticancer platinum drugs which can be accumulated or activated in the tumor tissue.

  2007cited by this paper
• The resurgence of platinum-based cancer chemotherapy

  2007cited by this paper
• Preclinical and clinical studies on the use of platinum complexes for breast cancer treatment.

  2007cited by this paper
• Photoactivatable platinum complexes.

  2007cited by this paper
• Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study.

  2006cited by this paper
• Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin.

  2006cited by this paper
• Phase I study of S-1 and nedaplatin for patients with recurrence of head and neck cancer.

  2006cited by this paper
• Platinum complexes as anticancer agents.

  2006influential reference
• Anti-tumor activity of heptaplatin in combination with 5-fluorouracil or paclitaxel against human head and neck cancer cells in vitro

  2006cited by this paper
• The Discovery and Development of Cisplatin

  2006cited by this paper
• Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs.

  2005cited by this paper
• Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation.

  2005cited by this paper
• Loading mitomycin C inside long circulating hyaluronan targeted nano‐liposomes increases its antitumor activity in three mice tumor models

  2004cited by this paper
• Pharmacokinetics and antitumor activity of a new platinum compound,cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl- 1, 3-dioxolane]platinum(II), as determined by ex vivo pharmacodynamics

  2004cited by this paper
• Combination Chemotherapy with 5-Fluorouracil and Heptaplatin as First-line Treatment in Patients with Advanced Gastric Cancer

  2004cited by this paper
• A Clinical Screening Cooperative Group phase II evaluation of lobaplatin (ASTA D-19466) in advanced head and neck cancer

  2004cited by this paper
• Phase II study of nedaplatin and irinotecan for elderly patients with advanced non-small cell lung cancer.

  2004cited by this paper
• Pilot Study of Heptaplatin, UFT-E and Leucovorin in Advanced Gastric Carcinoma.

  2003cited by this paper
• Tumour-inhibiting platinum complexes--state of the art and future perspectives.

  2003cited by this paper
• Cisplatin and platinum drugs at the molecular level. (Review).

  2003cited by this paper
• Nucleotide excision repair from site-specifically platinum-modified nucleosomes.

  2003cited by this paper
• Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).

  2003cited by this paper
• Oxaliplatin-related side effects: characteristics and management.

  2002cited by this paper
• The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae.

  2002cited by this paper
• Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals

  2002cited by this paper
• Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells.

  2002cited by this paper
• Binding to cisplatin-modified DNA by the Saccharomyces cerevisiae HMGB protein Nhp6A.

  2002cited by this paper
• Testis-specific HMG-domain protein alters the responses of cells to cisplatin.

  2002cited by this paper
• A Phase I study of cis‐malonato[(4R,5R)‐4,5‐bis(aminomethyl)‐1,3‐dioxolane] platinum(II) in patients with advanced malignancies

  2001cited by this paper
• Cisplatin: from DNA damage to cancer chemotherapy.

  2001cited by this paper
• Recognition of cisplatin adducts by cellular proteins.

  2001cited by this paper
• Matrix-induced fragmentation of P3'-N5' phosphoramidate-containing DNA: high-throughput MALDI-TOF analysis of genomic sequence polymorphisms.

  2001cited by this paper
• Current results and perspectives of the use of human tumor cell lines for antitumor drug screening

  2001cited by this paper
• Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.

  2000cited by this paper
• Determination by electrospray mass spectrometry of the outersphere association constants of DNA/platinum complexes using 20-mer oligonucleotides and ([Pt(NH(3))(4)](2+), 2Cl(-)) or ([Pt(py)(4)](2+), 2Cl(-)).

  2000cited by this paper
• Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin.

  2000cited by this paper
• Oxaliplatin in colorectal cancer: an overview.

  2000cited by this paper
• Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

  1999cited by this paper
• Medicinal inorganic chemistry: introduction.

  1999cited by this paper
• Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.

  1999cited by this paper
• Phase II clinical trial of SKI‐2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma

  1999cited by this paper
• Lobaplatin in advanced urothelial tract tumors. The Genitourinary Group of the European Organization for Research and Treatment of Cancer (EORTC).

  1997cited by this paper
• Lobaplatin in advanced urothelial tract tumors

  1997cited by this paper
• The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin.

  1996cited by this paper
• Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins.

  1996cited by this paper
• Lobaplatin (D-19466) in Patients with Advanced Non-Small-Cell Lung Cancer: A Trial of the Association for Medical Oncology (AIO) Phase II Study Group

  1996cited by this paper
• Pharmacokinetics and antitumor activity of a new platinum compound, cis-malonato[(4R,5R )-4,5-bis(aminomethyl)-2-isopropyl- 1, 3-dioxolane]platinum(II), as determined by ex vivo pharmacodynamics

  1995cited by this paper
• Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.

  1995cited by this paper
• A trial of lobaplatin (D-19466) in platinum-resistant ovarian cancer.

  1995cited by this paper
• Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.

  1994cited by this paper
• A PHASE-I STUDY OF IOBAPLATIN (D-19466) ADMINISTERED BY 72H CONTINUOUS INFUSION

  1993cited by this paper
• A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.

  1993cited by this paper
• New Cisplatin Analogues in Development

  1993cited by this paper
• A phase I study of lobaplatin (D-19466) administered by 72 h continuous infusion

  1993cited by this paper
• Ring-opening reactions of the anticancer drug carboplatin : NMR characterization of cis-[Pt(NH3)2(CBDCA-O)(5'-GMP-N7) in solution

  1993cited by this paper
• Pharmacokinetic and Pharmacodynamic Study with Lobaplatin (D-19466), a New Platinum Complex, after Bolus Administration

  1992cited by this paper
• Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinoma.

  1990cited by this paper
• Kinetics of the displacement of cyclobutane-1,1-dicarboxylate from diammine(cyclobutane-1,1-dicarboxylato)platinum(II) in aqueous solution

  1988cited by this paper
• [Tumor biochemistry as basis for advances in tumor chemotherapy].

  1986cited by this paper
• The structure of the antitumor complex cis-(diammino) (1,1-cyclobutanedicarboxylato)-Pt(II): X ray and nmr studies

  1980cited by this paper
• Inhibition of Dunning asc itic leukemia and Walker 256 carcinosarcoma with cis-diamminedichloroplatinum (NSC-119875).

  1970cited by this paper
• The successful regression of large solid sarcoma 180 tumors by platinum compounds.

  1970cited by this paper
• Platinum Compounds: a New Class of Potent Antitumour Agents

  1969cited by this paper
• Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

  1965cited by this paper

• Unravelling the Anticancer Potential of Schiff Base Functionalized Nanoparticles: Recent Developments and Future Challenges

  2026cites this paper
• QuEChERS and UPLC-MS/MS-Based Quantification of Human Plasma of Eight Nucleoside Reverse Transcriptase Inhibitors and Platinum Anticancer Drugs for Hepatocellular Carcinoma

  2025cites this paper
• Diorganotin(IV) Complexes Containing Hydrazone Ligands as Prospective Bioactive Agents: Synthesis, Crystal Structure, Spectroscopic Analysis, Anticancer, and Antimicrobial Activity

  2025cites this paper
• A glimpse into the developments, potential leads and future perspectives of anticancer cobalt complexes.

  2025cites this paper
• Cancer-affected tissue regeneration employing cisplatin-loaded polymeric nanoplatforms.

  2025cites this paper
• Recent Advances in Schiff Base Coinage Metal Complexes as Anticancer Agents: A Comprehensive Review (2021–2025)

  2025cites this paper
• Advancing Cancer-Targeted Nanotherapies with Tumor Homing Peptides.

  2025cites this paper
• QM/MM Based Study of Electronic Structure of Platinum Dihalides

  2025cites this paper
• Enhancing lobaplatin sensitivity in lung adenocarcinoma through inhibiting LDHA-targeted metabolic pathways

  2024cites this paper
• Pyrones Isolated from Annona Acutiflora Exhibit Promising Cytotoxic Effects on Cancer Cell Lines

  2024cites this paper
• Engineered hybrid carbon nanohorns-lipid platforms for the delivery of cisplatin to the colorectal cancer

  2024cites this paper
• Oxali-palladium nanoparticle synthesis, characterization, protein binding, and apoptosis induction in colorectal cancer cells

  2024cites this paper
• Platinum-based chemotherapy: trends in organic nanodelivery systems.

  2024cites this paper
• A fight against Cancer with Advancement of Schiff base metal complexes: Future Prospects

  2024cites this paper
• Design, Synthesis, and Investigation of Anticancer and Antioxidant Potential of Novel Indole‐Based Melatonin Analogues in Breast Cancer

  2024cites this paper
• Platinum-based chemotherapies-induced nephrotoxicity: mechanisms, potential treatments, and management

  2024cites this paper
• Protective effect of dental pulp stem cells' conditioned medium against cisplatin-induced testicular damage in rats.

  2024cites this paper
• Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli‐Responsive Nanocages

  2023cites this paper
• (Magnetic laponite/κ-carrageenan)@chitosan core–shell carrier for pH-sensitive release of doxorubicin

  2023cites this paper
• POTENTIAL AMELIORATIVE EFFECT OF PROPOLIS AGAINST THE DEVELOPMENTAL TOXICITY INDUCED BY OXALIPLATIN IN ALBINO RATS PRIOR AND DURING PREGNANCY

  2023cites this paper
• Evaluation of apoptotic and anti-metastatic effects by modified mesoporous silica nanoparticles (MSNs) with Zn and NH2 containing cisplatin on HT-29 cell line

  2023cites this paper
• Toll-like Receptor Agonist CBLB502 Protects Against Cisplatin-induced Liver and Kidney Damage in Mice

  2023cites this paper
• Biological activity of two water-soluble amino acid-Pt complexes: Synthesis, characterization, cytotoxicity, DNA interaction, and theoretical studies

  2023cites this paper
• Evaluation of toxicity and mutagenicity of oxaliplatin on germ cells in an alternative in vivo model Caenorhabditis elegans.

  2023cites this paper
• Novel ternary Pd(II) complexes as potent anticancer drugs for ovarian carcinoma treatment

  2023cites this paper
• Iminophosphine platinum(II) complexes containing long chain aniline derivatives: synthesis, characterization, and anticancer properties

  2023cites this paper
• Reactions of cobalt(ii) chloride and cobalt(ii) acetate with hemisalen-type ligands: ligand transformation, oxidation of cobalt and complex formation. Preliminary study on the cytotoxicity of Co(ii) and Co(iii) hemisalen complexes

  2023cites this paper
• Biomedical and clinical applications of platinum-based nanohybrids: An update review.

  2023cites this paper
• Synthesis, characterization, and biological activity of sterically hindered fluorine-containing platinum(II) complexes

  2023cites this paper
• Synthesis, biological evaluation and preliminary mechanisms of 6-amino substituted harmine derivatives as potential antitumor agents.

  2022cites this paper
• Drug Sensitivity Testing for Cancer Therapy, Key Areas.

  2022cites this paper
• Image Processing Pipeline to Compute Homologous Recombination Score

  2022cites this paper
• BERBERINE: A POTENT ADJUVANT IN PSORIASIS NANOTECHNOLOGY

  2022cites this paper
• The Acute Toxicities and Efficacy of Concurrent Chemotherapy With Docetaxel Plus Cisplatin, or Docetaxel, or Cisplatin and Helical Tomotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Single-Center Phase II Trial

  2022cites this paper
• Ligand Evolution in the Photoactivatable Platinum(IV) Anticancer Prodrugs

  2022cites this paper
• Metallo-Drugs in Cancer Therapy: Past, Present and Future

  2022cites this paper
• Quinoxaline: A Comprehension of current pharmacological advancement in medicinal chemistry

  2022cites this paper
• Synthesis and Structure Elucidation of Novel Spirooxindole Linked to Ferrocene and Triazole Systems via [3 + 2] Cycloaddition Reaction

  2022cites this paper
• Exosomes loaded with ultrasmall Pt nanoparticles: a novel low-toxicity alternative to cisplatin

  2022cites this paper
• VOCAL CORD PARALYSIS INDUCED BY OXALIPLATIN: DIFFERENCIAL DIAGNOSIS OF HYPERSENSITIVITY.

  2022cites this paper
• Synthesis and Evaluation in vitro of Novel Harmine Derivatives as Anticancer Activity Agents

  2022cites this paper
• Engineering biosafe cisplatin loaded nanostructured lipid carrier: optimisation, synthesis, pharmacokinetics and biodistribution

  2022cites this paper
• Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics

  2022cites this paper
• Synthesis and In Vitro Studies of Photoactivatable Semisquaraine-type Pt(II) Complexes

  2022cites this paper
• Cytoreductive Surgery (CRS) Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Platinum-Sensitive Recurrence Epithelial Ovarian Cancer With HRR Mutation: A Phase III Randomized Clinical Trial

  2022influential citation
• Ruthenium(II)-diphosphine complexes containing acylthiourea ligands are effective against lung and breast cancers.

  2022cites this paper
• Nanotechnology-Based Strategies for Berberine Delivery System in Cancer Treatment: Pulling Strings to Keep Berberine in Power

  2021cites this paper
• The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment

  2021cites this paper
• Evaluation of Risk Factors Causing Ototoxicity in Childhood Cancers Located in the Head and Neck Region Treated With Platinum-based Chemotherapy

  2021cites this paper
• Platinum (II) complexes and their nanoformulations: preparation, characterisation and cytotoxicity

  2021cites this paper
• F127/Cisplatin Microemulsions: In Vitro, In Vivo and Computational Studies

  2021cites this paper
• Triorganotin (IV) carboxylates as potential anticancer agents: Their synthesis, physiochemical characterization, and cytotoxic activity against HeLa and MCF‐7 cancer cells

  2021cites this paper
• New generation of viral nanoparticles for targeted drug delivery in cancer therapy

  2021cites this paper
• Platinum and Palladium Complexes as Promising Sources for Antitumor Treatments

  2021cites this paper
• Synthesis, Characterization and Antiproliferative Evaluation of Pt(II) and Pd(II) Complexes with a Thiazine-Pyridine Derivative Ligand

  2021cites this paper
• Protein-based drug carrier specific for HER2-positive breast cancer cells

  2020cites this paper
• Platinum(IV) antitumor complexes and their nano-drug delivery

  2020cites this paper
• In vitro antioxidant and cytotoxic activity of the root extract of Aspilia mossambicensis (Oliv) Wild (Asteraceae)

  2020influential citation
• Nano-organometallic complexes as therapeutic platforms against breast cancer cell lines; (invitro study)

  2020cites this paper
• Cutoff of 25% for Ki67 expression is a good classification tool for prognosis in colorectal cancer in the AJCC-8 stratification

  2020cites this paper
• Aberrant Sialylation in Cancer Metastasis

  2020cites this paper
• Synthesis, characterization, simulation, DNA binding and anticancer activities of Co(II), Cu(II), Ni(II) and Zn(II) complexes of a Schiff base containing o-hydroxyl group nitrogen ligand

  2020cites this paper
• Anticancer Medications and Sodium Dysmetabolism.

  2020cites this paper
• Recent Advances in Gold Complexes as Anticancer Agents

  2020cites this paper
• Cisplatin-Induced Nephrotoxicity in Mouse Kidney Cortical Collection Duct Cells: Protective Role of Curcumin

  2020cites this paper
• Cu (II) and Co (II/III) complexes of N,O‐chelated Schiff base ligands: DNA interaction, protein binding, cytotoxicity, cell death mechanism and reactive oxygen species generation studies

  2020cites this paper
• Insights into platinum-induced peripheral neuropathy–current perspective

  2020cites this paper
• HPLC methods for quantifying anticancer drugs in human samples: A systematic review.

  2020cites this paper
• Encapsulation of Nedaplatin in Novel PEGylated Liposomes Increases Its Cytotoxicity and Genotoxicity against A549 and U2OS Human Cancer Cells

  2020cites this paper
• Thermosensitive injectable hydrogel containing carboplatin loaded nanoparticles: A dual approach for sustained and localized delivery with improved safety and therapeutic efficacy

  2020cites this paper
• Metallodrug-driven combination chemotherapy in cancer treatment

  2020cites this paper
• The Antitumor Efficiency of Zinc Finger Nuclease combined with Cisplatin and Trichostatin A in Cervical Cancer Cells.

  2020cites this paper
• Microwave and conventional synthesis of ester based dicationic pyridinium ionic liquids carrying hydrazone linkage: DNA binding, anticancer and docking studies

  2020cites this paper
• Further Approaches in the Design of Antitumor Agents with Response to Cell Resistance: Looking toward Aza Crown Ether-dtc Complexes.

  2020cites this paper
• Anti-cancer and Anti-oxidant Potencies of Cuscuta reflexa Roxb. Plant Extracts

  2020cites this paper
• Myrrh induces the apoptosis and inhibits the proliferation and migration of gastric cancer cells through down-regulating cyclooxygenase-2 expression

  2020cites this paper
• Selective Coordination Mode of Acylthiourea Ligands in Half-Sandwich Ru(II) Complexes and Their Cytotoxic Evaluation.

  2020cites this paper
• Synthesis and antiproliferative activity of hindered, chiral 1,2-diaminodiamantane platinum(II) complexes.

  2020cites this paper
• Synthesis, Characterization and Anticancer Studies of Rh(I), Rh(III), Pd(II) and Pt(II) Complexes Bearing A Dithiooxamide Ligand

  2020cites this paper
• A rare case of urinary retention in an adult due to a primary penile Tumor

  2020cites this paper
• Oxaliplatin-induced Immune Thrombocytopenia: A Case Report and Literature Review.

  2020cites this paper
• Some new anticancer platinum complexes of dithiocarbamate derivatives against human colorectal and pancreatic cell lines

  2020cites this paper
• Chemo preventive effect of methanol extract of Anacardium occidentale nut shell on ultra-violet radiation induced skin damage

  2020cites this paper
• Antitumor Potential of Berberine and Cinnamic Acid against Solid Ehrlich Carcinoma in Mice.

  2019cites this paper
• Single-chain antibody against Reg4 suppresses gastric cancer cell growth and enhances 5-FU-induced cell death in vitro.

  2019cites this paper
• Lobaplatin Inhibits Prostate Cancer Proliferation and Migration Through Regulation of BCL2 and BAX

  2019cites this paper
• Loading of Cisplatin into Mesoporous Silica Nanoparticles: Effect of Surface Functionalization.

  2019cites this paper
• Gold Nanoparticles to Tackle Drug Resistance in Cancer

  2019cites this paper
• Investigation of binding behavior of important metal ions to thioredoxin reductase using mobility-shift affinity capillary electrophoresis: A preliminary insight into the development of new metal-based anticancer drugs

  2019cites this paper
• Synthesis, biological evaluation and molecular docking studies on the DNA and BSA binding interactions of palladium(II) and platinum(II) complexes featuring amides of tetrazol-1-yl- and tetrazol-5-ylacetic acids

  2019cites this paper
• The effects of Lactobacillus species isolated from traditional dairy products and Urtica extract on gastric cancer cell line

  2019cites this paper
• Novel pyridinium based ionic liquids with amide tethers: Microwave assisted synthesis, molecular docking and anticancer studies

  2019cites this paper
• s-Acetylide complexes for biomedical applications: Features, challenges and future directions

  2019cites this paper
• The antitumor effect of lobaplatin against Ishikawa endometrial cancer cells in vitro and in vivo.

  2019cites this paper
• Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity

  2019cites this paper
• Evaluation of mutagenic activity of platinum complexes in somatic cells of Drosophila melanogaster.

  2019cites this paper
• Versatile Pt NCs-based chemotherapeutic agents significantly induce the apoptosis of cisplatin-resistant non-small cell lung cancer.

  2019cites this paper
• Synthesis, structure and bonding modes of pyrazine based ligands of Cp*Rh and Cp*Ir complexes: The study of in-vitro cytotoxicity against human cell lines

  2019cites this paper
• Role of Unani Medicines in Cancer Control and Management

  2019cites this paper
• Synergistic Effect of Novel EGFR Inhibitor AZD8931 and p38α siRNA in Lung Adenocarcinoma Cancer Cells.

  2019cites this paper